Founded in 2006, Fournier-Majoie Foundation is a not-for-profit venture capital firm based in Brussels, Belgium. The firm seeks to invest in the oncology sector. The firm provides financial support to projects dealing with biomarkers, diagnostic tools, medical devices, and technology platforms.
Mablink Bioscience is a biotechnology company focused on developing a new class of cancer therapies known as Antibody Drug Conjugates (ADCs). The company specializes in designing homogeneous, plasma-stable ADCs that maintain their original pharmacological properties while achieving a high drug-to-antibody ratio (DAR). This innovative approach aims to provide healthcare professionals with enhanced treatment options for cancer patients, ultimately improving therapeutic outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.